HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study.

AbstractPURPOSE:
Prolongation of the QT interval is associated with an increased risk of arrhythmia, coronary heart disease (CHD), and mortality. Estrogens and androgens have been proposed as a causal factor in QT lengthening. We tested whether postmenopausal hormone replacement therapy was associated with prolonged QT intervals in a healthy population sample of women (mean age=54).
METHODS:
Women (n=3103) were asked about estrogen (ERT) and progestin plus estrogen (PERT) replacement therapy use at 4 examinations over 9 years. Electrocardiographic QT intervals were measured and corrected for heart rate using the QT Index (QTI) and Bazett's correction. QT prolongation was defined as QTI>110% and a change from baseline of >or=4%.
RESULTS:
Heart rate corrected QT length was moderately but significantly (p<0.01) greater, and the risk of QT prolongation was nearly twice (Odds Ratio=1.9, 95% Confidence Interval: 1.2-2.0) that in women who used ERT compared with never users. PERT use was not significantly associated with QT length.
CONCLUSIONS:
The potential for slight increases in QT length over time, and an increased risk of QT prolongation with ERT use identified in this observational study, are important concerns that should be further explored in randomized trials.
AuthorsMercedes R Carnethon, Mary S Anthony, Wayne E Cascio, Aaron R Folsom, Pentti M Rautaharju, Duanping Liao, Gregory W Evans, Gerardo Heiss
JournalAnnals of epidemiology (Ann Epidemiol) Vol. 13 Issue 7 Pg. 530-6 (Aug 2003) ISSN: 1047-2797 [Print] United States
PMID12932629 (Publication Type: Evaluation Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Arteriosclerosis (etiology)
  • Cohort Studies
  • Electrocardiography
  • Estrogen Replacement Therapy (adverse effects)
  • Female
  • Humans
  • Long QT Syndrome (chemically induced, complications, physiopathology)
  • Longitudinal Studies
  • Middle Aged
  • Prospective Studies
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: